Literature DB >> 22819717

Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion.

Junping Ao1, Jiao Meng, Lei Zhu, Huizhen Nie, Chenchen Yang, Jinjun Li, Jianren Gu, Qiushi Lin, Weiwen Long, Xiaoqun Dong, Chao Li.   

Abstract

Androgen receptor (AR) activity is associated with cancer development and progression. In hepatocellular carcinoma (HCC), AR contributes to HCC incidence, but the role of AR in HCC cell migration and invasion remains largely unknown. In this study, we found that AR was expressed at high levels in a subgroup of HCC cell lines with high metastatic potential. Experiments using lentiviral overexpression or small hairpin RNA knockdown of AR as well as activation of AR by its ligand indicated that AR activation promoted HCC cell migration and invasion. We also found that AR activation enhanced the expression of a metastasis-promoting gene, ID1, which led to increased HCC cell migration and invasion. An AR antagonist was able to block this process, suggesting that AR activation in AR-positive HCC may be therapeutically inhibited as a potential intervention strategy.
Copyright © 2012 Federation of European Biochemical Societies. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819717      PMCID: PMC5528389          DOI: 10.1016/j.molonc.2012.06.005

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  32 in total

Review 1.  Helix-loop-helix proteins in mammary gland development and breast cancer.

Authors:  Pierre-Yves Desprez; Tomoki Sumida; Jean-Philippe Coppé
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.

Authors:  Terence K Lee; Ronnie T P Poon; Anthony P Yuen; Ming Tat Ling; Xiang Hong Wang; Yong Chuan Wong; Xin Yuan Guan; Kwan Man; Zao You Tang; Sheung Tat Fan
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

Review 3.  Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.

Authors:  P J Johnson
Journal:  J Gastroenterol Hepatol       Date:  1999-05       Impact factor: 4.029

4.  Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer.

Authors:  Ju-Seog Lee; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

Review 5.  Novel insights on imaging sex-hormone-dependent tumourigenesis in vivo.

Authors:  Balaji Ramachandran; Alessia Stell; Luca Maravigna; Adriana Maggi; Paolo Ciana
Journal:  Endocr Relat Cancer       Date:  2011-04-02       Impact factor: 5.678

6.  Sex-steroid receptors in the diethylnitrosamine model of hepatocarcinogenesis: modifications by gonadal ablation and steroid replacement therapy.

Authors:  S Tejura; G R Rodgers; M H Dunion; M A Parsons; J C Underwood; P M Ingleton
Journal:  J Mol Endocrinol       Date:  1989-11       Impact factor: 5.098

Review 7.  A decade's studies on metastasis of hepatocellular carcinoma.

Authors:  Zhao-You Tang; Sheng-Long Ye; Yin-Kun Liu; Lun-Xiu Qin; Hui-Chuan Sun; Qin-Hai Ye; Lu Wang; Jian Zhou; Shuang-Jian Qiu; Yan Li; Xue-Ning Ji; Hu Liu; Jing-Ling Xia; Zhi-Quan Wu; Jia Fan; Zeng-Chen Ma; Xin-Da Zhou; Zhi-Ying Lin; Kang-Da Liu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-18       Impact factor: 4.553

8.  Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage.

Authors:  Nicole M Martin; Barham K Abu Dayyeh; Raymond T Chung
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

9.  Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma.

Authors:  Wen-Lung Ma; Cheng-Lung Ma; Cheng-Lung Hsu; Ming-Heng Wu; Chun-Te Wu; Cheng-Chia Wu; Jiann-Jyh Lai; Yuh-Shan Jou; Chun-Wei Chen; Shuyuan Yeh; Chawnshang Chang
Journal:  Gastroenterology       Date:  2008-05-22       Impact factor: 22.682

10.  Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B.

Authors:  Sheng-Han Wang; Shiou-Hwei Yeh; Wei-Hsiang Lin; Hurng-Yi Wang; Ding-Shinn Chen; Pei-Jer Chen
Journal:  Hepatology       Date:  2009-11       Impact factor: 17.425

View more
  14 in total

1.  Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion.

Authors:  Junping Ao; Jiao Meng; Lei Zhu; Huizhen Nie; Chenchen Yang; Jinjun Li; Jianren Gu; Qiushi Lin; Weiwen Long; Xiaoqun Dong; Chao Li
Journal:  Mol Oncol       Date:  2012-07-05       Impact factor: 6.603

2.  Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives.

Authors:  Y E Tian; X U Xie; Yao Lin; Guang Tan; W U Zhong
Journal:  Oncol Lett       Date:  2015-03-10       Impact factor: 2.967

3.  Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression.

Authors:  Anees M Dauki; James S Blachly; Esko A Kautto; Sameera Ezzat; Mohamed H Abdel-Rahman; Christopher C Coss
Journal:  Cancer Res       Date:  2019-11-04       Impact factor: 12.701

Review 4.  Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers.

Authors:  Tatsuo Kanda; Xia Jiang; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

5.  Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma.

Authors:  Huizhen Nie; Qingzhen Cao; Lei Zhu; Yuehua Gong; Jianren Gu; Zuping He
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

Review 6.  AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.

Authors:  Michael T Schweizer; Evan Y Yu
Journal:  Cancers (Basel)       Date:  2017-01-11       Impact factor: 6.639

Review 7.  Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Authors:  Mahmoud A Ali; Sahin Lacin; Reham Abdel-Wahab; Mark Uemura; Manal Hassan; Asif Rashid; Dan G Duda; Ahmed O Kaseb
Journal:  Onco Targets Ther       Date:  2017-03-03       Impact factor: 4.147

8.  Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Authors:  Dongyun Yang; Diana L Hanna; Josh Usher; Jordan LoCoco; Pritesh Chaudhari; Heinz-Josef Lenz; V Wendy Setiawan; Anthony El-Khoueiry
Journal:  Cancer       Date:  2014-07-31       Impact factor: 6.921

Review 9.  The androgen receptor as an emerging target in hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Osamu Yokosuka
Journal:  J Hepatocell Carcinoma       Date:  2015-06-26

Review 10.  Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy.

Authors:  Zhengxiao Zhao; Zhiyuan Bo; Weiyi Gong; Yong Guo
Journal:  Int J Med Sci       Date:  2020-04-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.